메뉴 건너뛰기




Volumn 26, Issue 1, 2004, Pages 3-8

Pharmacokinetics of Omeprazole in Healthy Adults and in Children with Gastroesophageal Reflux Disease

Author keywords

Children; Gastroesophageal reflux disease; Omeprazole; Pharmacokinetics

Indexed keywords

OMEPRAZOLE;

EID: 0942265378     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200402000-00003     Document Type: Article
Times cited : (28)

References (18)
  • 1
    • 0029860237 scopus 로고    scopus 로고
    • Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease
    • Hatlebakk JG, Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet. 1996;31:386-406.
    • (1996) Clin Pharmacokinet , vol.31 , pp. 386-406
    • Hatlebakk, J.G.1    Berstad, A.2
  • 2
    • 0033761045 scopus 로고    scopus 로고
    • Selection of drugs to treat gastrooesophageal reflux disease: The role of drug interactions
    • Flockhart DA, Desta Z, Mahal SK. Selection of drugs to treat gastrooesophageal reflux disease: the role of drug interactions. Clin Pharmacokinet. 2000;39:295-309.
    • (2000) Clin Pharmacokinet , vol.39 , pp. 295-309
    • Flockhart, D.A.1    Desta, Z.2    Mahal, S.K.3
  • 3
    • 0024214265 scopus 로고
    • Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
    • Lind T, Cederberg C, Forssell H, et al. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol. 1988;23:1259-1266.
    • (1988) Scand J Gastroenterol , vol.23 , pp. 1259-1266
    • Lind, T.1    Cederberg, C.2    Forssell, H.3
  • 4
    • 0027295014 scopus 로고
    • Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
    • Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr. 1993;123:148-154.
    • (1993) J Pediatr , vol.123 , pp. 148-154
    • Gunasekaran, T.S.1    Hassall, E.G.2
  • 5
    • 0033637537 scopus 로고    scopus 로고
    • Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements
    • International Pediatric Omeprazole Study Group
    • Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr. 2000;137:800-807.
    • (2000) J Pediatr , vol.137 , pp. 800-807
    • Hassall, E.1    Israel, D.2    Shepherd, R.3
  • 6
    • 0033759927 scopus 로고    scopus 로고
    • Pharmacokinetics of orally administered omeprazole in children
    • International Pediatric Omeprazole Pharmacokinetic Group
    • Andersson T, Hassall E, Lundborg P, et al. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group. Am J Gastroenterol. 2000;95:3101-3106.
    • (2000) Am J Gastroenterol , vol.95 , pp. 3101-3106
    • Andersson, T.1    Hassall, E.2    Lundborg, P.3
  • 7
    • 0035008328 scopus 로고    scopus 로고
    • A review of omeprazole use in the treatment of acid-related disorders in children
    • Zimmermann AE, Walters JK, Katona BG, et al. A review of omeprazole use in the treatment of acid-related disorders in children. Clin Ther. 2001; 23:660-679.
    • (2001) Clin Ther , vol.23 , pp. 660-679
    • Zimmermann, A.E.1    Walters, J.K.2    Katona, B.G.3
  • 8
    • 0024835315 scopus 로고
    • Clinical pharmacokinetics in infants and children. A reappraisal
    • Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children. A reappraisal. Clin Pharmacokinet. 1989;17(Suppl 1):29-67.
    • (1989) Clin Pharmacokinet , vol.17 , Issue.SUPPL. 1 , pp. 29-67
    • Kearns, G.L.1    Reed, M.D.2
  • 9
    • 0023217333 scopus 로고
    • Effect of maturation on drug disposition in pediatric patients
    • Stewart CF, Hampton EM. Effect of maturation on drug disposition in pediatric patients. Clin Pharm. 1987;6:548-564.
    • (1987) Clin Pharm , vol.6 , pp. 548-564
    • Stewart, C.F.1    Hampton, E.M.2
  • 10
    • 0028102713 scopus 로고
    • Pharmacokinetics in children
    • Routledge PA. Pharmacokinetics in children. J Antimicrob Chemother. 1994;34(Suppl A):19-24.
    • (1994) J Antimicrob Chemother , vol.34 , Issue.SUPPL. A , pp. 19-24
    • Routledge, P.A.1
  • 11
    • 0025044933 scopus 로고
    • Pharmacokinetics of various single intravenous and oral doses of omeprazole
    • Andersson T, Cederberg C, Regardh CG, et al. Pharmacokinetics of various single intravenous and oral doses of omeprazole. Eur J Clin Pharmacol. 1990;39:195-197.
    • (1990) Eur J Clin Pharmacol , vol.39 , pp. 195-197
    • Andersson, T.1    Cederberg, C.2    Regardh, C.G.3
  • 12
    • 0026100421 scopus 로고
    • Influence of acid secretory status on absorption of omeprazole from enteric coated granules
    • Andersson T, Bergstrand R, Cederberg C. Influence of acid secretory status on absorption of omeprazole from enteric coated granules. Br J Clin Pharmacol. 1991;31:275-278.
    • (1991) Br J Clin Pharmacol , vol.31 , pp. 275-278
    • Andersson, T.1    Bergstrand, R.2    Cederberg, C.3
  • 13
    • 0024811797 scopus 로고
    • The role of therapeutic drug monitoring in children
    • Boreus LO. The role of therapeutic drug monitoring in children. Clin Pharmacokinet. 1989;17(Suppl 1):4-12.
    • (1989) Clin Pharmacokinet , vol.17 , Issue.SUPPL. 1 , pp. 4-12
    • Boreus, L.O.1
  • 14
    • 0035023973 scopus 로고    scopus 로고
    • A rapid HPLC-DAD method for separation and determination of omeprazole extracted from human plasma
    • Dubuc MC, Hamel C, Caubet MS, et al. A rapid HPLC-DAD method for separation and determination of omeprazole extracted from human plasma. J Liquid Chromotagr Rel Technol. 2001;24:1161-1169.
    • (2001) J Liquid Chromotagr Rel Technol , vol.24 , pp. 1161-1169
    • Dubuc, M.C.1    Hamel, C.2    Caubet, M.S.3
  • 16
    • 0029896612 scopus 로고    scopus 로고
    • Pharmacokinetics and drug interactions - Relevant factors for the choice of a drug
    • Zech K, Steinijans VW, Huber R, et al. Pharmacokinetics and drug interactions - relevant factors for the choice of a drug. Int J Clin Pharmacol Ther. 1996;34:S3-S6.
    • (1996) Int J Clin Pharmacol Ther , vol.34
    • Zech, K.1    Steinijans, V.W.2    Huber, R.3
  • 17
    • 0025272633 scopus 로고
    • Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects
    • Andersson T, Andren K, Cederberg C, et al. Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects. Br J Clin Pharmacol. 1990;29:557-563.
    • (1990) Br J Clin Pharmacol , vol.29 , pp. 557-563
    • Andersson, T.1    Andren, K.2    Cederberg, C.3
  • 18
    • 0029919037 scopus 로고    scopus 로고
    • Bioavailability and efficacy of omeprazole given orally and by nasogastric tube
    • Larson C, Cavuto NJ, Flockhart DA, et al. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. Dig Dis Sci. 1996;41: 475-479.
    • (1996) Dig Dis Sci , vol.41 , pp. 475-479
    • Larson, C.1    Cavuto, N.J.2    Flockhart, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.